Hypoglycaemia and cognitive function in diabetes
- PMID: 11594296
Hypoglycaemia and cognitive function in diabetes
Abstract
The human brain is almost totally dependent on a continuous supply of glucose, deprivation of which rapidly causes malfunction. In the brain there are regional differences in the susceptibility to neuroglycopenia with the cerebral cortex being most sensitive while deeper structures are more resistant. A fall in blood glucose provokes a hierarchy of responses including secretion of counter-regulatory hormones and development of warning symptoms which alert the individual to treat the hypoglycaemia. Symptoms are generated when blood glucose falls to specific threshold concentrations, although these are dynamic and can be modified by various factors. Symptoms can be classified as autonomic and neuroglycopenic, with the latter being related to altered cognitive functioning. Acute hypoglycaemia produces electroencephalographic (EEG) changes as well as neurophysiological abnormalities including increased latency and/or reduced amplitude of sensory evoked potentials. At blood glucose below 3 mmol/l cognitive functioning becomes impaired but the degree of dysfunction differs in various domains and a battery of psychometric tests are required to assess impairment of cognitive function during hypoglycaemia. Complex, attention-demanding and speed-dependent responses are most impaired with accuracy often preserved at the expense of speed. Cognitive function does not recover fully until 40-90 min after blood glucose is restored to normal. Hypoglycaemia also provokes changes in mood, increases anxiety and may induce depression and fear of further hypoglycaemia, which can modify behaviour and influence quality of glycaemic control. Recurrent severe hypoglycaemia may have long-term sequelae in the form of cumulative cognitive impairment and impaired awareness of hypoglycaemia.
Similar articles
-
The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness.Diabet Med. 1996 Jul;13(7):607-15. doi: 10.1002/(SICI)1096-9136(199607)13:7<607::AID-DIA159>3.0.CO;2-I. Diabet Med. 1996. PMID: 8840093 Review.
-
Hypoglycaemia and cognitive function.Diabetes Obes Metab. 2005 Sep;7(5):493-503. doi: 10.1111/j.1463-1326.2004.00421.x. Diabetes Obes Metab. 2005. PMID: 16050942 Review.
-
Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state.Diabetologia. 2003 Jan;46(1):53-64. doi: 10.1007/s00125-002-0948-9. Epub 2002 Nov 9. Diabetologia. 2003. PMID: 12637983
-
Attentional functioning is impaired during acute hypoglycaemia in people with Type 1 diabetes.Diabet Med. 2006 Jan;23(1):26-31. doi: 10.1111/j.1464-5491.2005.01795.x. Diabet Med. 2006. PMID: 16409562
-
Alanine infusion during hypoglycaemia partly supports cognitive performance in healthy human subjects.Diabet Med. 2004 May;21(5):440-6. doi: 10.1111/j.1464-5491.2004.01174.x. Diabet Med. 2004. PMID: 15089788
Cited by
-
Management of diabetes mellitus medications in the nursing home.Drugs Aging. 2005;22(3):209-18. doi: 10.2165/00002512-200522030-00003. Drugs Aging. 2005. PMID: 15813654 Review.
-
Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes.Health Qual Life Outcomes. 2009 Oct 22;7:91. doi: 10.1186/1477-7525-7-91. Health Qual Life Outcomes. 2009. PMID: 19849828 Free PMC article.
-
The impact of type 1 diabetes on neural activity serving attention.Hum Brain Mapp. 2019 Mar;40(4):1093-1100. doi: 10.1002/hbm.24431. Epub 2018 Oct 27. Hum Brain Mapp. 2019. PMID: 30368968 Free PMC article.
-
Glycemic control and weight reduction without causing hypoglycemia: the case for continued safe aggressive care of patients with type 2 diabetes mellitus and avoidance of therapeutic inertia.Mayo Clin Proc. 2010 Dec;85(12 Suppl):S15-26. doi: 10.4065/mcp.2010.0468. Epub 2010 Nov 24. Mayo Clin Proc. 2010. PMID: 21106867 Free PMC article. Review.
-
Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes.Pediatr Diabetes. 2015 May;16(3):164-76. doi: 10.1111/pedi.12263. Epub 2015 Feb 12. Pediatr Diabetes. 2015. PMID: 25683037 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Medical